Importancia de la vitamina D en la salud de la mujerenfoque multidisciplinar

  1. José L. Gallo Vallejo
  2. David Gallo Padilla
  3. Francisco Javier Gallo Vallejo
Aldizkaria:
Toko-ginecología práctica

ISSN: 0040-8867

Argitalpen urtea: 2015

Zenbakia: 741

Orrialdeak: 63-70

Mota: Artikulua

Beste argitalpen batzuk: Toko-ginecología práctica

Laburpena

Vitamin D plays an important role in the health of women. In pregnant women, low levels of 25-hydroxyvitamin D have been linked to infertility, preeclampsia, gestational diabetes and increased rate of cesarean section. Severe maternal deficiency determined in the neonate: low birth weight, delayed or decreased growth, skeletal problems in childhood, neonatal hypocalcemia, hypocalcemia seizures, alterations in tooth enamel, heart failure and increased risk of HIV transmission and congenital rickets. Furthermore, vitamin D deficiency is a known risk factor for osteoporosis, falls and hip fractures in the elderly population, so that any preventive or therapeutic strategy osteoporosis happens, inevitably, to achieve levels adequate calcium and vitamin D. Finally, vitamin D deficiency is associated with other diseases such as osteomalacia, sarcopenia and the increased prevalence of certain cancers.

Erreferentzia bibliografikoak

  • Berti C, Decsi T, Dykes F, et al. Critical issues in setting micronutrient recommendations for pregnant women: an insight. Matern Child Nutr 2010;6:5-22.
  • Barret H, McElduff A. Vitamin D and pregnancy: An old problem revisited. Best Pract Res Clin Endocrinol Metab 2010:24(4):527-39.
  • Bischoff-Ferrari HA. Vitamin D –role in pregnancy and early childhood. Ann Nutr Metab 2011;59:17-21.
  • Biesalki HK. Vitminan D recommendations – beyond deficiency. Ann Nutr Metab 2011;59:10-6.
  • Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007 Sep;92(9):3517-22.
  • Baker AM, Haeri S, Camargo CA, et al. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab 2010;95:5105-5109.
  • Maghbooli Z, Hossein-Nezhad A, Karimi F, Shafael AR, Larijani B. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes/Metabolism Research and Reviews 2008;24:27-32.
  • González de Agüero Laborda R, Fabre González E. Aporte de vitamina D y embarazo. Laboratorio Italfármaco.
  • Powe CE, Seely EW, Rana S, et al. First trimester vitamin D binding protein, and subsequent preeclampsia. Hypertension 2010;56:758-63.
  • World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva: WHO Press; 2011.p. 1-38.
  • Achkar M, Dodds L, Giguère Y, Forest J, Armson BA, Woolcott C, Agellon S, Spencer A, Weiler HA Vitamin D status in early pregnancy and risk of preeclampsia. Am J Obstet Gynecol 2014 Nov 13. pii: S0002-9378(14)02208-X. doi: 10.1016/j.ajog.2014.11.009.
  • Bener A, Al-Hamaq AO, Saleh NM. Association between vitamin D insufficiency and adverse pregnancy outcome: global comparisons. Int J Womens Health 2013 Sep 4;5:523-31
  • Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011 Oct;26(10):2341-57.
  • Wagner CL, Baggerly C, McDonnell SL, Baggerly L, Hamilton SA, Winkler J, et al. Post-hoc comparison of vitamin D status at three timepoints during pregnancy demonstrates lower risk of preterm birth with higher vitamin D closer to delivery. J Steroid Biochem Mol Biol 2014 Nov 13. pii: S0960-0760(14)00268-4. doi: 10.1016/j.jsbmb. 2014.11.013.
  • Merewood A, Mehta SD, Chen TC, Bauchner H, Holick MF. Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab 2009 Mar;94(3):940-5.
  • Hollis BW, Wagner CL. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int 2013 Feb;92(2):128-39
  • Savvidou MD, Makgoba M, Castro PT, Akolekar R, Nicolaides KH. First-trimester maternal serum vitamin D and mode of delivery. Br J Nutr 2012 Dec 14;108(11):1972-5.
  • Mulligan FL Felton SK, Riek AE, Bernal- Mizrachi C. Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol 2010 May;202 (5):429.e1.
  • Weinert LS, Silveiro SP. Maternal-fetal impact of vitamin d deficiency: a critical review. Matern Child Health J 2015 Jan;19(1):94-101. doi: 10.1007/s10995-014-1499-7.
  • Food and Nutrition Board. Dietary Reference Intakes for calcium and vitamin D. Report brief. November 2010. Institute of Medicine of the National Academies. Disponible en: www.iom.edu/vitamind
  • Hollis BW, Wagner CL. Vitamin D requirements and supplementation during pregnancy. Curr Opin Endocrinol Diabetes Obes 2011;18:371-5.
  • Finer S, Khan KS, Hitman GA, Griffiths C, Martineau A, Meads C. Inadequate vitamin D status in pregnancy: evidence for supplementation. Acta Obstetricia et Gynecologica Scandinavica 2012;91:159-63.
  • Carcel C, Quiles J, Rico B, Sanchis T. Adecuación de la ingesta nutricional de embarazadas de segundo y tercer trimestre. Rev Esp Nutr Comunitaria 2005;11(3):136-44.
  • Food and Nutrition Board. Institute of Medicine. Dietary Reference intakes. Washington DC:National Academy Press, 2006.
  • Anexo: Vitaminas y minerales que pueden declararse y sus cantidades diarias recomendadas. RD 1669/2009. BOE 2009;269:92956-92959.
  • Fabre E, Haya J, Bartha JL, Gallo M, González de Agüero R, Melchor JC. Nutrición en el embarazo. Documentos de Consenso de la SEGO. Madrid, 2008.
  • Fármacos y gestación: Protocolo Nº 37 SEGO(actualizado en 2004). Prog Obstet Ginecol 2005;48(2):106-10.
  • Specker B. Vitamin D requirements during pregnancy. Am J Clin Nutr 2004;80(6)1740S-1747S.
  • Cabezuelo G, Vidal S, Abedelo A, Frontera P. Niveles de 25-hidroxivitamina D en lactantes. Relación con la lactancia materna. An Pediatr (Bar) 2007;66:491-5.
  • Silva Rico JC, Silva Higuero N. Raquitismo carencial y otras formas de raquitismo. Pediatr Integral 2011; XV(7): 654-68.
  • Erkkola M, Kaila M, Nwaru BI, Kronberg- Kippilä C, Ahonen S, Nevalainen J, Veijola R, Pekkanen J, Ilonen J, Simell O, Knip M, Virtanen SM: Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy 2009; 39: 875–82.
  • Delaney MF. Strategies for the prevention and treatment of osteoporosis during early postmenopause. Am J Obstet Gynecol 2006;194:S12-23.
  • Brincat M, Gambin J, Brincat M, Calleja-Agius J. The role of vitamin D in osteoporosis. Maturitas (2015), http://dx.doi.org/10.1016/j.maturitas.2014.12.018
  • Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-73.
  • Bischoff-Ferrari H, Dawson-Hughes B, Villet W, Staehelin H, Bazemore M, Lee R, et al. Effect of vitamin D on falls. JAMA 2004;291:1999-2006.
  • Mendoza N, Santalla A, Morón F, Martínez T, González A, Quereda F, et al. Características epidemiológicas de una población de mujeres posmenopáusicas con osteopenia y osteoporosis: importancia de la dieta mediterránea. Prog Obst Ginecol 2008;51(5):265-70.
  • National Osteoporosis Foundation’s Updated Recommendations for Calcium and Vitamin D Intake; 26 July 2007. Disponible en: http://www.nof.org/ prevention/calcium_and_VitaminD.htm
  • Guadalix S, Jódar E. Vitamina D y función muscular. REEMO 2007;16(2):41-4.
  • Baró F, Cano A, Cancelo MJ, Estévez A, Fernández JM, González SP, y cols. Menoguía. Osteoporosis. Cano Sánchez A (editor invitado). AEEM 2012.
  • Grupo de trabajo de la Guía de Práctica Clínica sobre Osteoporosis y Prevención de Fracturas por Fragilidad. Guía de Práctica Clínica sobre Osteoporosis y Prevención de Fracturas por Fragilidad. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad, Política Social e Igualdad. Agència d´Informació, Avaluació i Qualitat en Salut (AIAQS) de Cataluña; 2010. Guías de Práctica Clínica en el SNS: AATRM Nº 2007/02.
  • Russell JA. Osteomalacic ostheopaty. Muscle Nerve 1994;17:578-80.
  • Visser M, Deeg DJ, Lips P. Longitudinal Aging Study Amsterdam. Lowvitamin D and high parathyroid hormone levels as determinants ofloss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003 Dec;88(12):5766-72.
  • Burgos Peláez R. Enfoque terapéutico global de la sarcopenia. Nutr Hosp 2006;21:51-60.
  • Shui I, Giovannucci E. Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol 2014;810:33-51.
  • Obaidi J, Musallam E, Al-Ghzawi HM1, Azzeghaiby SN, Alzoghaibi IN.. Vitamin D and its relationship with breast cancer: an evidence based practice paper. Glob J Health Sci 2014 Sep 27;7(1):261-6.
  • Manson JE, Bassuk SS, Lee IM, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemporary Clinical Trials. 2012;33(1):159-71.